NCT00362895 - A Bioequivalence Study of Tobradex AF | Biotech Hunter

Enrollment

995

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

August 31, 2006

Study Completion Date

August 31, 2006

Conditions

Cataract

Interventions

DRUG

Tobramycin 0.3% / Dexamethasone 0.033% ophthalmic suspension

One drop in the study eye, single dose

DRUG

Tobramycin 0.3% / Dexamethasone 0.1% ophthalmic suspension (TOBRADEX)

One drop in the study eye, single dose

Trial Locations (1)

Contact Alcon for Trial Location(s), Fort Worth